Prognostic factors for overall survival in patients with chronic myeloid leukemia treated with imatinib at the National Cancer Institute – Mexico, from 2000 to 2016

por Ylescas‐Soria, Jimena, de la Torre‐Lujan, Alfredo H., Herrera, Luis A., Miranda, Daniela, Grimaldo, Flavio, Rivas, Silvia, Cervera, Eduardo, Meneses‐García, Abelardo, Leon-Sarmiento, Fidias E., Prada, Diddier
Publicado 2019